Author: cmx

NVM Private Equity (NVM) continues to expand the VCT team with the addition of Alex Wilson and Stephen Johnson. NVM’s recruitment strategy has been to build on their existing strong regional presence with a growing VCT team to help develop the business in a changed environment by bringing in people with experience in new, fast-emerging

Pure Pet Food, the award-winning manufacturer of dehydrated and freeze dried pet food has secured a £2m investment from NVM Private Equity(NVM) to accelerate its plans to make healthy choices for pet owners easy and accessible. Their low processed natural recipes have become the go-to option for pets suffering with a range of ailments and

NVM Private Equity (“NVM”) has completed an equity investment in UK fintech company Mojo Mortgages (“Mojo”, the “Business” or the “Company”), a leading online mortgage comparison and processing platform. The investment is part of a wider £7 million funding round and will support Mojo’s ambitious growth plans and help the Company continue to evolve its

NVM Private Equity (NVM) has invested £2.25 million of growth capital into Edinburgh-based software business Administrate as part of a £3.78 million investment round alongside existing investors Archangels and the Scottish Investment Bank. Administrate is a Software-as-a-Service Training and Learning Management Platform, designed to help manage and automate the entire process of delivering education. The

Mo connected with NVM at a London showcase event in 2018 hosted by Creative England which offered an opportunity for early-stage companies to pitch to potential investors. NVM were immediately impressed with co-founder and CEO Luke Fisher, and there has been an alignment of interest from day one, since there are many different tools to make investments,

NVM invested £3 million in the management buy-out of Lanner in March 2010 and has pro-actively supported the business throughout its ownership, helping the management team to grow and develop the company. Lanner specialises in predictive simulation for industrial clients. Their technology connects physical assets, processes and resources into a single digital model that delivers

Sam joins NVM as Talent Director and has over 10 years’ experience in executive search, assessment and advisory experience in the technology markets. NVM believes that access to the right people and expertise can make all the difference when it comes to scaling a business and Sam’s primary remit will be to build, develop and

Founder and climbing enthusiast Ged MacDomhnaill formed TCH in 2010. Identifying the opportunity for a new fitness and leisure concept, TCH targets climbers and non-climbers looking for a sociable way to keep fit. Through events such as their UV climbing club night, TCH has established a recognisable brand in a fast growing and fragmented market.

The investment from NVM will help Clarilis to continue on its growth trajectory, with the funding enabling the team to accelerate their strategic initiatives and capitalise on the strong market demand they are experiencing. Co-founded by James and Kevin Quinn, Clarilis launched its solution in 2015 and has quickly established itself as a leading platform

Founded in 2015 and headquartered at the world-renowned International Centre for Life in Newcastle (an incubator space for young and established biotechnology companies) Newcells is a successful, early-stage, life-sciences spinout from Newcastle University, which is leading the way in the development of Human Induced Pluripotent Stem Cells (hiPSCs) for efficacy and toxicity testing in the

Flexioffices (Flexi), one of the UK’s leading serviced office brokers, has secured £8.2 million of investment from NVM Private Equity (NVM) as part of the funding package for a management buyout. The investment from NVM will help to accelerate Flexi’s international growth and drive continued development of their technology. The deal is NVM’s second management

The Ablatus technology was originally developed by clinicians in the Norfolk and Norwich University Hospitals NHS Foundation Trust(the Trust), who identified a novel way to address some of the issues with radiofrequency ablation. The Trust has since been working alongside HEE to commercialise the invention and their efforts led to the formation of Ablatus in